Hrt Financial »

4d Molecular Therapeutics In shares owned by Hrt Financial

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Hrt Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $202k 10k 20.22
2023-09-30 $331k 26k 12.72
2022-06-30 $261k 38k 6.97

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Linde SHS (LIN)
Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
CRH Ord (CRH)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Align Technology (ALGN)
Spdr S&p 500 Etf Tr Put
Home Depot (HD)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Hrt Financial

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In